CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 790696-790881
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T58127","span":{"begin":0,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The use of complement inhibitors in treating immune mediated neuropathies merits further investigation; however, they may be more efficacious in the hyperacute phase of these disorders."}
Epistemic_Statements
{"project":"Epistemic_Statements","denotations":[{"id":"T1731","span":{"begin":0,"end":185},"obj":"Epistemic_statement"}],"text":"The use of complement inhibitors in treating immune mediated neuropathies merits further investigation; however, they may be more efficacious in the hyperacute phase of these disorders."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T325","span":{"begin":0,"end":185},"obj":"Sentence"}],"text":"The use of complement inhibitors in treating immune mediated neuropathies merits further investigation; however, they may be more efficacious in the hyperacute phase of these disorders."}